Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concentrations of protease inhibitors in cord blood after in utero exposure.
Mirochnick M, Dorenbaum A, Holland D, Cunningham-Schrader B, Cunningham C, Gelber R, Mofenson L, Culnane M, Connor J, Sullivan JL. Mirochnick M, et al. Pediatr Infect Dis J. 2002 Sep;21(9):835-8. doi: 10.1097/00006454-200209000-00010. Pediatr Infect Dis J. 2002. PMID: 12352805 Clinical Trial.
Pharmacokinetics and tolerance of zidovudine in preterm infants.
Capparelli EV, Mirochnick M, Dankner WM, Blanchard S, Mofenson L, McSherry GD, Gay H, Ciupak G, Smith B, Connor JD; Pediatric AIDS Clinical Trials Group 331 Investigators. Capparelli EV, et al. Among authors: mirochnick m. J Pediatr. 2003 Jan;142(1):47-52. doi: 10.1067/mpd.2003.mpd0335. J Pediatr. 2003. PMID: 12520254 Clinical Trial.
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F. Jackson JB, et al. Among authors: mirochnick m. Lancet. 2003 Sep 13;362(9387):859-68. doi: 10.1016/S0140-6736(03)14341-3. Lancet. 2003. PMID: 13678973 Clinical Trial.
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Cressey TR, Jourdain G, Lallemant MJ, Kunkeaw S, Jackson JB, Musoke P, Capparelli E, Mirochnick M. Cressey TR, et al. Among authors: mirochnick m. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):283-8. J Acquir Immune Defic Syndr. 2005. PMID: 15735445 Clinical Trial.
Nevirapine concentrations in newborns receiving an extended prophylactic regimen.
Mirochnick M, Nielsen-Saines K, Pilotto JH, Pinto J, Jiménez E, Veloso VG, Parsons T, Watts DH, Moye J, Mofenson LM, Camarca M, Bryson Y; NICHD/HPTN 040/PACTG 1043 Protocol Team. Mirochnick M, et al. J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):334-7. J Acquir Immune Defic Syndr. 2008. PMID: 18398973 Clinical Trial.
Lopinavir exposure with an increased dose during pregnancy.
Mirochnick M, Best BM, Stek AM, Capparelli E, Hu C, Burchett SK, Holland DT, Smith E, Gaddipati S, Read JS; PACTG 1026s Study Team. Mirochnick M, et al. J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):485-91. doi: 10.1097/QAI.0b013e318186edd0. J Acquir Immune Defic Syndr. 2008. PMID: 18989231 Free PMC article. Clinical Trial.
170 results